Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease. - Wikidata - wikimedia - TriplyDB

Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease.

Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease.

http://www.wikidata.org/entity/Q45299599

about

Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease Role of cerebral cortex in the neuropathology of Huntington's disease Mouse models of polyglutamine diseases in therapeutic approaches: review and data table. Part II.Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease.Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington's disease.Decreased Lin7b expression in layer 5 pyramidal neurons may contribute to impaired corticostriatal connectivity in huntington disease.Functional Changes in Neocortical Activity in Huntington's Disease Model Mice: An in vivo Intracellular Study.Impaired alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor trafficking and function by mutant huntingtin.The role for alterations in neuronal activity in the pathogenesis of polyglutamine repeat disorders.Abnormal burst patterns of single neurons recorded in the substantia nigra reticulata of behaving 140 CAG Huntington's disease mice Pathological cell-cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington's disease The group 2 metabotropic glutamate receptor agonist LY379268 rescues neuronal, neurochemical and motor abnormalities in R6/2 Huntington's disease mice Dysfunction of the ubiquitin ligase Ube3a may be associated with synaptic pathophysiology in a mouse model of Huntington disease Allosteric activation of M4 muscarinic receptors improve behavioral and physiological alterations in early symptomatic YAC128 mice.A role for Kalirin-7 in corticostriatal synaptic dysfunction in Huntington's disease The corticostriatal pathway in Huntington's disease.Downregulation of cannabinoid receptor 1 from neuropeptide Y interneurons in the basal ganglia of patients with Huntington's disease and mouse models.Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of disease Location, location, location: contrasting roles of synaptic and extrasynaptic NMDA receptors in Huntington's disease.Genetic mouse models of Huntington's disease: focus on electrophysiological mechanisms.Dopamine and glutamate in Huntington's disease: A balancing act.Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function.Corticostriatal circuit dysfunction in Huntington's disease: intersection of glutamate, dopamine and calcium.Huntington's Disease: Pathogenic Mechanisms and Therapeutic Targets.Cognitive dysfunction in Huntington's disease: mechanisms and therapeutic strategies beyond BDNF.Dysregulation of Corticostriatal Connectivity in Huntington's Disease: A Role for Dopamine Modulation Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease.Impaired long-term potentiation in the prefrontal cortex of Huntington's disease mouse models: rescue by D1 dopamine receptor activation.Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntington's disease.Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load.

P2860

Q24657764-A40B735F-865B-4BE0-9541-89D51C66D94D Q26829211-4DABF3DA-AF74-4ED5-B4EB-9CFE4A7F05DD Q27005950-F84FD62C-EA9A-41A7-87E1-AE2882227EE2 Q30490632-704BE21A-E61D-4010-9E4C-67BF3486D5A4 Q33573371-46A45E03-45B6-45E3-896C-827D4DDA18BA Q33663335-1380F106-2139-4B13-8AF3-9BC5CD57F1ED Q35055109-F214833E-8C23-48BE-A421-923568894B46 Q35311070-30E6F718-EBCD-4558-9E50-6D35EA580E05 Q35340099-14D56BE6-FA9E-47E8-B8B9-CFEBD768E5C0 Q35774197-62152FF3-BB8C-4A6C-AAC0-5A2470D9A0B4 Q35828444-FB6E3303-6B43-4364-80FD-A8CCAF232FB1 Q36037085-9203F603-B4AE-49CC-94F8-97C111F0D197 Q36216036-C9C8658F-04C9-4BBA-B28D-B5790D69566A Q36300365-09064892-FA95-44B1-80E8-63D43B75EDD0 Q36331582-E950614D-B832-4CAA-A702-6E5CEEB5FE20 Q36684263-B2C31910-FC66-4EC8-ABD9-3C7BF65BF92B Q36975938-D3A9E5F8-CE4C-47B6-9F49-37F13A29DC1D Q37311202-366D33DE-CB69-4FB9-91D4-D38C2C9629AE Q37691539-9827390A-CBA8-4C41-AA52-5186D3BC703C Q37731940-9EFF2A03-C143-41A7-ABEB-88109153D611 Q37734563-283D9E47-1B2E-40D2-8AF9-9C18A98C72E9 Q37930190-5C18D537-F1A2-4BFB-B37B-29099FEB455A Q38603960-AEBF9D53-49EC-4269-B513-D5A9C2068515 Q38663090-D6C4683F-3086-4164-B386-7BFC4B1DC0D1 Q38928777-EC4914B0-5D76-4A5D-9A3D-CA3204CFC065 Q39041217-7D4A2DB6-90B5-4DE4-B3F9-AD42AC2D6621 Q42469950-E8F202A5-391D-4234-95C7-BD428F74C314 Q42688388-236A2562-5D76-4A11-B57A-776CDB8DBA1E Q45302139-2723D430-D776-4C00-850E-AA294459A727 Q45306738-104EB78E-8A4C-4BAE-8092-C526C76647C6

P2860

Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease.

http://www.wikidata.org/entity/Q45299599

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease.

@en

Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease.

@nl

type

label

Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease.

@en

Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease.

@nl

prefLabel

Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease.

@en

Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease.

@nl

P1433

Q45299599-9DD6CABD-730D-4512-B5E0-FE965872DC64

P1476

Q45299599-46C09C6E-B00E-4E09-9E66-66130142E2B4

P2093

Q45299599-79DFBE15-FA8F-46BF-B419-F13560094681

Q45299599-7E8B3863-4975-4FFB-B96F-B80D9D03A6B7

Q45299599-8AA79D90-E9DB-41BB-8FFB-5F8762A12108

Q45299599-B6475AA3-4D2C-4D80-AE03-FE61CA3CAC61

Q45299599-F6548C88-D86D-4E84-B2F9-E13CF6F9148F

P2860

Q45299599-029C69F6-0700-4F0E-AD6D-26062D690E6B

Q45299599-0D581F5B-F686-44F0-861C-25BE0568BEAE

Q45299599-0E84A13D-1EFF-4280-9916-FBA6F7A7F00D

Q45299599-1048CE17-9B58-4256-A206-BB28328E5366

Q45299599-135F6A49-949F-44BB-B391-C8639B8302B2

Q45299599-1A446803-47D7-4D20-B587-9829C4616E90

Q45299599-1B5E7A8D-5471-4ACE-9492-C6AE98C9ADDB

Q45299599-2E58C0E9-0D21-4622-88D5-4E6EB398AD46

Q45299599-2EE0DC40-EC77-4CF3-A357-2C7005B246EB

Q45299599-305C3688-AC3E-45B6-99FB-BBBB43F8E901

P304

Q45299599-9D12B022-7184-48DA-9C11-CF0363E1ADAB

P31

Q45299599-A1FE177D-1937-4758-933A-DD54D2E9F074

P356

Q45299599-4B084609-2823-4735-9C0A-8C8C2F61D081

P407

Q45299599-1D92CEC1-4BD1-4F19-AD96-AB5FEA89AFAA

P433

Q45299599-CBC7D940-4C4D-4619-B120-47C21700DCCC

P478

Q45299599-E37FE1B5-876B-45AE-8A31-9C4C838356C0

P577

Q45299599-8683F639-1EF6-496F-A872-C73865750041

P5875

Q45299599-9EBDE1FF-05F6-4C67-BE15-A9583DB2F6F4

P698

Q45299599-97A76A79-1C8F-4E9F-A0DB-D985FB78A766

P921

Q45299599-9C70D497-BF6B-4A0A-8119-BD878670E31B

P356

P1433

Journal of Neurophysiology

P1476

Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease.

@en

P2093

Angela Venegas

http://www.w3.org/2001/XMLSchema#string

Carlos Cepeda

http://www.w3.org/2001/XMLSchema#string

Michael S Levine

http://www.w3.org/2001/XMLSchema#string

Véronique M André

http://www.w3.org/2001/XMLSchema#string

Yeranui Gomez

http://www.w3.org/2001/XMLSchema#string

P2860

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation

Impaired learning-dependent cortical plasticity in Huntington's disease transgenic mice

Developmental and regional expression in the rat brain and functional properties of four NMDA receptors

AMPA protects cultured neurons against glutamate excitotoxicity through a phosphatidylinositol 3-kinase-dependent activation in extracellular signal-regulated kinase to upregulate BDNF gene expression

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

Cloned glutamate receptors

Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-D-aspartate receptors via post-synaptic density 95.

Frontal-striatal disconnection disrupts cognitive performance of the frontal-type in the rat.

AMPA receptor potentiators for the treatment of CNS disorders.

Long-term regulation of excitatory and inhibitory synaptic transmission in hippocampal cultures by brain-derived neurotrophic factor.

P304

2108-2119

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/JN.01118.2005

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P577

2005-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7389236

http://www.w3.org/2001/XMLSchema#string

P698

16381805

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease